Europeans' ancient ancestors passed down genes tied to multiple sclerosis, Alzheimer's risk

Migrations of ancient humans in Eurasia may have impacted modern Europeans' risk of developing a variety of diseases, such as (MS), and . That's according to two new papers published Wednesday (Jan. 10) in the . Along with two from the same researchers, the papers include analyses of from the bones and teeth of hundreds of ancient individuals, the oldest of whom date to the , or Middle Stone Age.

The scientists compared these people's DNA to the genomes of present day Europeans. The project sheds light on the genetic legacy of three ancient human migrations into different regions of Europe: the around 45,000 years ago; Neolithic farmers from the Middle East approximately 11,000 years ago; and sheep and cattle farmers from the Pontic Steppe, a region that spans Eastern Europe and central Asia, around .

In all, the researchers compared the genomes of 1,750 ancient people with those of around 410,000 people who contributed data to a large repository called the U.K. Biobank. All the modern individuals self identified as British and white, and the authors estimated how much ancient DNA was passed on to them.

One of the new papers identified gene variants linked to the autoimmune disease MS that were carried by the Pontic Steppe farmers as they migrated mainly into northern Europe; this may help explain why the disease is . The researchers concluded these risk variants were "positively selected," meaning they offered some benefit to the migrants and were thus under evolutionary pressure to emerge.

Specific gene variants related to immune function are . These include HLA gene variants, which help the body . However, like a double edged sword, certain HLA variants are also , where the body attacks its own cells. In the past, these variants potentially helped ancient farmers combat infectious diseases from their animals, the study authors theorize.

However, as people's lifestyles changed over time, in terms of their hygiene, diets and medicine, the variants took on new meaning. Understanding the evolutionary forces that drove these genes' selection could have implications for treating MS, the study authors hypothesize. Thinking about the double edged sword, "what we need to move towards is to try to recalibrate the immune response," rather than completely eliminating it, , co senior study author and a professor of neuroimmunology at the University of Oxford in the U.K., said during a press conference on Jan.

9. In another paper, the authors traced the inheritance of genetic risk variants for 35 complex traits, meaning those caused by a combination of many genes and their interactions with the environment. They discovered that genes associated with lactose tolerance in adults emerged in Europe around 6,000 years ago, and that Northern Europeans today may tend to be partly due to inheriting genes from the Pontic Steppe farmers.

They also found that people who carry more DNA from the hunter gather group they studied may have a greater genetic risk of developing type 2 diabetes and Alzheimer's disease than people who carry fewer of those gene variants. Modern populations with this hunter gather DNA largely live in Eastern Europe.

Alzheimer's risk variants may have been positively selected — for example, one risk variant called of developing Alzheimer's but may in women. The fertility boost may have given our ancestors a "huge advantage," , co senior study author and professor of virology and immunology at the University of Oxford, said during the conference.

At first glance, the findings "fit well with the notion of evolutionary 'trade offs' maintaining disease associated variants in the population, answering the question of why disease susceptibility is not eliminated by negative selection," , a professor of evolutionary anthropology at the University at Buffalo in New York who was not involved in the research, told Live Science in an email.

— — — These two studies looked for correlations between specific gene variants and the incidence of different diseases. Because of this, they can't prove that inheriting these ancient gene variants definitively these diseases in Europeans today. "What these papers are doing is they're setting the framework of how you can use these ancient human genomes to understand the origins and spread of disease risk," , the director of the project and an evolutionary geneticist at the University of Cambridge and the University of Copenhagen, said during the press conference..